You Might Also Like: Unseen Upside: Investments Beyond Their Returns

Introducing S4:E5 Unlocking the Dark Genome for Lupus and other Autoimmune Diseases from Unseen Upside: Investments Beyond Their Returns. Follow the show: Unseen Upside: Investments Beyond Their Returns

Autoimmune diseases like lupus impact over 5 million patients globally, but treatment options remain limited. Now, decoding the once mysterious "dark genome" could bring new therapies. Over 90% of our DNA was once considered "junk"—but we’ve learned this dark matter regulates gene expression and human disease. This episode takes you to the pioneers who are unlocking the dark genome's potential to correct root causes of complex conditions like lupus. We'll chat with those illuminating this uncharted territory and developing novel approaches. Guests include:

Rosana Kapeller, M.D., Ph.D., Co-Founder, President, & CEO at Rome Therapeutics

Steve Kafka, General Partner at S32

Keri Mastrogiacomo, mother of a Lupus patient

Katherine Cavanagh, Associate Investment Director at Cambridge Associates 

Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company. Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.

DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].